Companies: 10,795·Total market cap: $144.5T
Adagio Medical Holdings, Inc.

Adagio Medical Holdings, Inc.

ADGMNASDAQHealthcare● Active
$0.72
$-0.00(-0.15%)
Market Cap$11019367
P/E Ratio
52W High$2.582
52W Low$0.7

Adagio Medical Holdings, Inc. (ADGM) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

adgm · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Adagio Medical Holdings, Inc. (ADGM) measures how much investors pay for each dollar of the company's trailing earnings. ADGM's current PE ratio of N/A is calculated by dividing its stock price of $0.72 by its TTM earnings per share of -$1.10.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-1.35
Based on 2 analysts
EPS (TTM)
-$1.10
TTM · diluted EPS
PEG Ratio
-0.01
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Adagio Medical Holdings, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2020 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Adagio Medical Holdings, Inc.
Adagio Medical Holdings, Inc.You
ADGM
$11MN/A-$1.10
Allurion Technologies Inc.
Allurion Technologies Inc.
ALUR
$6MN/A-$0.38
Athira Pharma, Inc.
Athira Pharma, Inc.
ATHA
$27MN/A-$24.70
Envoy Medical, Inc.
Envoy Medical, Inc.
COCH
$14MN/A-$1.21
Co-Diagnostics, Inc.
Co-Diagnostics, Inc.
CODX
$6MN/A-$35.25
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc.
CTXR
$7MN/A-$3.38
IRIDEX Corporation
IRIDEX Corporation
IRIX
$19MN/A-$0.26

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1.51
2024-12-31
FY2024
$-3.54
2023-12-31
FY2023
$-4.86
2022-12-31
FY2022
$-1.23
2021-12-31
FY2021
$-1.04
2020-12-31
FY2020
$-0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Adagio Medical Holdings, Inc. (ADGM) measures how much investors pay for each dollar of the company's trailing earnings. ADGM's current PE ratio of N/A is calculated by dividing its stock price of $0.72 by its TTM earnings per share of -$1.10.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.72 ÷ -$1.10 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

ADGM pe ratio · 6 questions

ADGM's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.72 and TTM EPS of -$1.10. Data sourced from Financial Modeling Prep via ADGM's SEC 10-K and 10-Q filings.

ADGM PE ratioWhat is ADGM PE ratioCurrent PE ratio of ADGMADGM PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Adagio Medical Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08